1. Home
  2. EVTL vs GNLX Comparison

EVTL vs GNLX Comparison

Compare EVTL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$0.80

Market Cap

235.6M

Sector

Industrials

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.65

Market Cap

133.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
GNLX
Founded
2016
2001
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.6M
133.0M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
EVTL
GNLX
Price
$0.80
$2.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$12.70
$17.25
AVG Volume (30 Days)
8.5M
279.5K
Earning Date
03-24-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.47
EPS
N/A
N/A
Revenue
N/A
$8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$2.29
52 Week High
$7.35
$8.54

Technical Indicators

Market Signals
Indicator
EVTL
GNLX
Relative Strength Index (RSI) 25.76 43.66
Support Level N/A $2.39
Resistance Level $1.42 $3.07
Average True Range (ATR) 0.11 0.21
MACD -0.03 -0.01
Stochastic Oscillator 2.26 26.72

Price Performance

Historical Comparison
EVTL
GNLX

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: